ClinicalTrials.govpublic full text
Oral Guanabenz for Multiple Sclerosis
multiple sclerosis, relapsing-remitting, multiple sclerosis, neuroprotection, clinical trial, safety and tolerability, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1030373
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.